LENSAR, Inc. Common Stock (LNSR) is a publicly traded Healthcare sector company. As of August 6, 2026, LNSR trades at $5.65 with a market cap of $68.53M and a P/E ratio of 5.85. LNSR moved +0.00% today. Year to date, LNSR is -49.87%; over the trailing twelve months it is -55.29%. Its 52-week range spans $4.95 to $17.31. Analyst consensus is buy with an average price target of $8.50. Rallies surfaces LNSR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for LNSR shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $5.65 |
| Market Cap | $68.53M |
| P/E Ratio | 5.85 |
| EPS | $0.98 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.31 |
| 52-Week Low | $4.95 |
| Volume | 877 |
| Avg Volume | 0 |
| Revenue (TTM) | $57.70M |
| Net Income | $29.40M |
| Gross Margin | 45.71% |
2 analysts cover LNSR: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.50.